What to Expect at Your Retina Exam
Retina exams are typically more involved than a routine eye exam. At Texas Retina, we make every effort to evaluate, test, diagnose and treat you all on the same day. As a
read more
Know the Early Warning Signs of a Retinal Detachment
The retina is the layer of nerve cells lining the back wall inside the eye. It senses light and sends signals to the brain so you can see. The vitreous is the
read more
Happy Thanksgiving!
All Texas Retina Associates offices will be closed Thursday, November 27, and Friday, November 28, for the Thanksgiving holiday. During this time of reflection and gratitude, we want you to know how
read more
Celebrating Family Caregivers
Did you know that more than 63 million Americans are now caregivers? That is one in every four adults. In honor of National Family Caregivers Month, Texas Retina would like to recognize
read more
Control Your Diabetes to Protect Your Vision
November is National Diabetes Month and Diabetic Eye Disease Awareness Month. Diabetes is a disease that occurs when your blood sugar, also known as blood glucose, is too high. It damages blood
read more
Dr. Abbey Doses First Patient in Phase 1b/2a LOTUS-2 Clinical Trial of Novel Multivalent Fusion Antibody EB-105 for Diabetic Macular Edema
On October 28, 2025, Texas Retina Associates Director of Clinical Research for Dallas Ashkan Abbey, MD, dosed the first patient in the Phase 1b/2a LOTUS-2 clinical trial of novel multivalent fusion antibody (EB-105) for diabetic
read more
Dr. Rene Choi Inducted into International Retina Imaging Society
Texas Retina’s Rene Y. Choi, MD, PhD, was inducted into the prestigious International Retina Imaging Society (IntRIS) on October 29, 2025. A private, nonprofit professional membership society, the mission of IntRIS is
read more
Texas Retina Breaks Ground on New Frisco Ophthalmology Complex
We’re excited to announce that on October 14, 2025, Texas Retina broke ground on a new, state-of-the-art eye care complex to better serve the Frisco, Texas community. Scheduled to open in late 2026,
read more
Texas Retina Participating in New Phase III Clinical Trial for Uveal Melanoma
Under the leadership of principal investigator Timothy Fuller, MD, Texas Retina will soon begin enrolling patients in the OptimUM-10 clinical trial, a randomized, Phase III, open-label study of neoadjuvant darovasertib in subjects with primary non-metastatic
read more
Getting to Know Benjamin R. Lin, MD
Board-certified ophthalmologist and retina specialist Benjamin R. Lin, MD, joined Texas Retina in September and cares for patients in our Dallas Main, Dallas North and Plano offices. He came to us from
read more